Cinobufagin treatment of relapsed or refractory hematological malignant tumor: 8 cases report and literatures review.

Author: Lu WANG ^{1
,

2} ; Ruihua MI ¹ ; Xudong WEI ¹ ; Lin CHEN ¹ ; Hao AI ¹ ; Qingsong YIN ¹ ; Ping WANG ¹ ;
Author Information

1. Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University
2. Henan Cancer Hospital, Zhengzhou 450000, China.
Publication Type:Case Reports
MeSH: Bufanolides; therapeutic use; Hematologic Neoplasms; drug therapy; Humans; Recurrence
From: Chinese Journal of Hematology 2015;36(11):954-956
CountryChina
Language:Chinese